Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve 1) To approve Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The company has informed BSE that a Board meeting is scheduled for May 30, 2026 to approve the Standalone Audited Financial Results for the quarter and financial year ended March 31, 2026. This is a routine regulatory intimation under SEBI (LODR) Regulations. No actual financial figures or results are disclosed in this filing — it is merely the pre-meeting notice. The approved results will be published on BSE's website after the meeting concludes.
This is a standard board meeting notice with no immediate impact on the stock. The actual financial results, when released, will determine any shareholder or stock price impact.